{"id":"NCT04462536","sponsor":"NoNO Inc.","briefTitle":"Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis","officialTitle":"A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-12-06","primaryCompletion":"2023-08-31","completion":"2023-08-31","firstPosted":"2020-07-08","resultsPosted":"2025-06-22","lastUpdate":"2025-06-22"},"enrollment":850,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Stroke, Acute"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Nerinetide","otherNames":["NA-1"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Nerinetide","type":"EXPERIMENTAL"}],"summary":"The primary purpose of this study is to determine if a single dose of nerinetide can reduce global disability in people who have had a stroke and are selected for endovascular therapy without the use of a tissue plasminogen activator (alteplase, tenecteplase, or equivalent).","primaryOutcome":{"measure":"Number of Participants With Independent Functioning on the Modified Rankin Scale (mRS), as Defined by a Score of 0-2","timeFrame":"90 days","effectByArm":[{"arm":"Placebo","deltaMin":181,"sd":null},{"arm":"Nerinetide","deltaMin":206,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":81,"countries":["United States","Australia","Canada","Germany","Italy","Netherlands","Norway","Singapore","Switzerland"]},"refs":{"pmids":["39955119"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":148,"n":393},"commonTop":["Urinary Tract infection","Hypotension","Haemorrhagic transformation stroke","Hypokalaemia","Headache"]}}